Warning: The NCBI web site requires JavaScript to function. more...
Expression and function of the insulin receptor substrate proteins in cancer.
Mardilovich K, Pankratz SL, Shaw LM.
Cell Commun Signal. 2009 Jun 17;7:14.
Related citations
Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis.
Gibson SL, Ma Z, Shaw LM.
Cell Cycle. 2007 Mar 15;6(6):631-7. Epub 2007 Mar 7. Review.
Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S, Côté S, Simard J.
Mol Endocrinol. 2000 Feb;14(2):229-40.
Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH, Byron SA, Cui X, Lee AV, Yee D.
Mol Cancer Res. 2008 Sep;6(9):1491-8.
Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG, White MF, Yee D.
J Biol Chem. 1998 Apr 17;273(16):9994-10003.
Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.
Shaw LM.
Mol Cell Biol. 2001 Aug;21(15):5082-93.
Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1.
Pankratz SL, Tan EY, Fine Y, Mercurio AM, Shaw LM.
J Biol Chem. 2009 Jan 23;284(4):2031-7. Epub 2008 Dec 4.
Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
Ma Z, Gibson SL, Byrne MA, Zhang J, White MF, Shaw LM.
Mol Cell Biol. 2006 Dec;26(24):9338-51. Epub 2006 Oct 9.
Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV.
Cancer Res. 2006 May 15;66(10):5304-13.
The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer.
Cell Cycle. 2011 Jun 1;10(11):1750-6. Epub 2011 Jun 1. Review.
Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.
Nolan MK, Jankowska L, Prisco M, Xu S, Guvakova MA, Surmacz E.
Int J Cancer. 1997 Sep 4;72(5):828-34.
Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA, Surmacz E.
Cancer Res. 1997 Jul 1;57(13):2606-10.
Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
Brüning JC, Winnay J, Cheatham B, Kahn CR.
Mol Cell Biol. 1997 Mar;17(3):1513-21.
Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
Solow BT, Harada S, Goldstein BJ, Smith JA, White MF, Jarett L.
Mol Endocrinol. 1999 Oct;13(10):1784-98.
Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton.
Clark SF, Martin S, Carozzi AJ, Hill MM, James DE.
J Cell Biol. 1998 Mar 9;140(5):1211-25.
PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
Weng LP, Smith WM, Brown JL, Eng C.
Hum Mol Genet. 2001 Mar 15;10(6):605-16.
Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S, Majchrzak B, Wang PC, Modi S, Khan MK, Fish EN, Platanias LC.
Biochem Biophys Res Commun. 2000 Apr 2;270(1):158-62.
The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors.
Uddin S, Fish EN, Sher D, Gardziola C, Colamonici OR, Kellum M, Pitha PM, White MF, Platanias LC.
Blood. 1997 Oct 1;90(7):2574-82.
Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.
J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):213-25. Review.
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X, Yee D.
Br J Cancer. 2006 Nov 6;95(9):1220-8. Epub 2006 Oct 17.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on